Malaria in Pregnancy Clinical Trial
Official title:
New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa.
Malaria in pregnancy contributes substantially to maternal anaemia and low birth weight:
effective malaria control in pregnancy could avoid about 10,000 maternal and up to 200,000
infant deaths every year. Intermittent preventive treatment with the drug
sulfadoxine-pyrimethamine (IPTp-SP), administered at least twice during routine antenatal
clinics, is recommended by the World Health Organization for areas of moderate to high
malaria transmission, including Sub-Saharan Africa.
Studies carried out in Kenya and Malawi before 2004 had showed that two doses of IPTp-SP
significantly reduce maternal anaemia, placental malaria parasitaemia and low birth weight.
However, in countries where this strategy had been introduced as part of national policy,
the coverage of the target population has varied widely, with estimates of 33-93% for uptake
of one dose and 24-68% for two doses, and no country had reached the goal of 80% of pregnant
women receiving at least 2 doses of IPTp. New approaches designed to improve IPTp coverage
were therefore urgently needed.
This study was therefore set up in 2002, in order to evaluate the additional effect of a
targeted promotional campaign on antenatal clinics utilization and on coverage and uptake of
Intermittent preventive treatment with sulfadoxine-pyrimethamine in a rural health district
in Burkina Faso; and to investigate the effectiveness of intermittent preventive treatment
with the sulfadoxine-pyrimethamine compared with weekly chloroquine, in order to provide
additional evidence to the Burkinabé Ministry of Health for an impending policy change.
Status | Completed |
Enrollment | 2766 |
Est. completion date | December 2006 |
Est. primary completion date | October 2006 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Female - First or second trimester of pregnancy - First or second pregnancy - Resident in the study area Exclusion Criteria: - Refuse to give informed consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Burkina Faso | District Sanitaire | Boromo |
Lead Sponsor | Collaborator |
---|---|
Institute of Tropical Medicine, Belgium | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Liverpool School of Tropical Medicine, National Laboratory of Public Health,Burkina Faso, University of Ouagadougou, Burkina Faso |
Burkina Faso,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Birth weight | At delivery | No | |
Secondary | Anemia | At 32 weeks gestation and at delivery | No | |
Secondary | Peripheral and placental parasitaemia | At 32 weeks gestation (peripheral) and at delivery (both) | No | |
Secondary | Gestational age | At first antenatal visit | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03508349 -
Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda
|
N/A | |
Completed |
NCT01053325 -
Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
|
Phase 3 | |
Completed |
NCT00140517 -
Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
|
N/A | |
Recruiting |
NCT05306067 -
Plasmodium Falciparum Genomic Intelligence in Mozambique
|
||
Recruiting |
NCT05757167 -
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
|
Phase 4 | |
Active, not recruiting |
NCT01555255 -
Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria
|
N/A | |
Completed |
NCT01136850 -
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
|
Phase 3 | |
Terminated |
NCT04148690 -
Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania
|
N/A | |
Completed |
NCT04160026 -
Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya
|
Phase 4 | |
Completed |
NCT04783051 -
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
|
Phase 3 | |
Not yet recruiting |
NCT05348746 -
ERASE - Impact of COVID-19 on Malaria Control
|
||
Completed |
NCT03998839 -
TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study
|
||
Completed |
NCT03208179 -
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
|
Phase 3 | |
Completed |
NCT01120145 -
Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi
|
N/A | |
Completed |
NCT00852423 -
Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria
|
Phase 3 | |
Completed |
NCT00680732 -
Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component
|
Phase 4 | |
Recruiting |
NCT03754322 -
LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial
|
N/A | |
Not yet recruiting |
NCT03944317 -
Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)
|
N/A | |
Completed |
NCT05294406 -
Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia
|
Phase 4 | |
Recruiting |
NCT04825782 -
MiMBa Pregnancy Registry
|